RSS

Rosetta Genomics and Collaborators Unveil Colon Cancer Screening Diagnostic.: An article from: BIOTECH Patent News-Gale Reference Team

  • Title: Rosetta Genomics and Collaborators Unveil Colon Cancer Screening Diagnostic.: An article from: BIOTECH Patent News
  • Author: Gale Reference Team
  • Released: 0000-00-00
  • Language:
  • Pages: 0
  • ISBN:
  • ISBN13:
  • ASIN: B001VMKCVI

DOWNLOAD CLICK HERE

Excerpt. © Reprinted by permission. All rights reserved.

Rosetta Genomics Ltd. (Rehovot, Israel) and collaborators, unveiled initial data relating to the company's colorectal cancer screening diagnostics test, miRscreen colon, which is based on a simple blood draw, and is expected to be released next year. The company's scientists and collaborators have identified microRNA biomarkers in serum, which have the potential to accurately differentiate colorectal cancer patients from healthy individuals.

"The initial data presented by Rosetta is very significant" said Aaron Ciechanover, Nobel laureate and chairman of Rosetta's scientific advisory board. "Rosetta's scientists and their collaborators, have for the first time, identified in serum, potential microRNA biomarkers of colorectal cancer. If treated early, 90% of colon cancer patients survive. The humane, medical, and financial... pdf
 
0 Comment

Posted by